RMD Resmed Inc

  1. Stocks
  2. Healthcare
  3. NYSE: RMD

Price (delayed)

$197.04

Market cap

$28.95B

P/E Ratio

30.22

Dividend/share

$1.92

EPS

$6.52

Enterprise value

$29.88B

ResMed is a San Diego, California-based medical equipment company. It primarily provides cloud-connectable medical devices for the treatment of sleep apnea , chronic obstructive pulmonary disease , and other respiratory ...

Highlights
Resmed's debt has decreased by 32% YoY and by 16% QoQ
RMD's equity is up by 18% year-on-year and by 3.3% since the previous quarter
The price to earnings (P/E) is 30% lower than the 5-year quarterly average of 45.6 but 8% higher than the last 4 quarters average of 29.6
Sector: Healthcare
Industry: Medical Instruments & Supplies
Website: https://www.resmed.com/
Peers: MDT TMO ELMD MASI

Key stats

What are the main financial stats of RMD
Market
Shares outstanding
146.91M
Market cap
$28.95B
Enterprise value
$29.88B
Valuations
Price to earnings (P/E)
30.22
Price to book (P/B)
6.26
Price to sales (P/S)
6.32
EV/EBIT
24.12
EV/EBITDA
20.53
EV/Sales
6.52
Earnings
Revenue
$4.58B
EBIT
$1.24B
EBITDA
$1.46B
Free cash flow
$1.09B
Per share
EPS
$6.52
Free cash flow per share
$7.41
Book value per share
$31.48
Revenue per share
$31.19
TBVPS
$23.66
Balance sheet
Total assets
$6.81B
Total liabilities
$2.18B
Debt
$1.17B
Equity
$4.63B
Working capital
$1.58B
Liquidity
Debt to equity
0.25
Current ratio
3.04
Quick ratio
1.32
Net debt/EBITDA
0.64
Margins
EBITDA margin
31.7%
Gross margin
55.8%
Net margin
20.9%
Operating margin
26.5%
Efficiency
Return on assets
14.1%
Return on equity
21.9%
Return on invested capital
32%
Return on capital employed
20.5%
Return on sales
27%
Dividend
Dividend yield
0.97%
DPS
$1.92
Payout ratio
29.4%

RMD stock price

How has the Resmed stock price performed over time
Intraday
-5.42%
1 week
-3.01%
1 month
5.63%
1 year
-11.1%
YTD
14.54%
QTD
2.94%

Financial performance

How have Resmed's revenue and profit performed over time
Revenue
$4.58B
Gross profit
$2.56B
Operating income
$1.21B
Net income
$958.38M
Gross margin
55.8%
Net margin
20.9%
The company's revenue rose by 14% YoY
The gross profit has grown by 13% YoY and by 3% from the previous quarter
RMD's net income is up by 11% YoY and by 8% QoQ
RMD's operating income is up by 9% YoY and by 6% QoQ

Growth

What is Resmed's growth rate over time

Valuation

What is Resmed stock price valuation
RMD P/E details
P/E
30.22
P/B
6.26
P/S
6.32
EV/EBIT
24.12
EV/EBITDA
20.53
EV/Sales
6.52
The price to earnings (P/E) is 30% lower than the 5-year quarterly average of 45.6 but 8% higher than the last 4 quarters average of 29.6
The EPS has increased by 11% YoY and by 8% from the previous quarter
RMD's P/B is 30% below its 5-year quarterly average of 9.4 but 7% above its last 4 quarters average of 6.2
RMD's equity is up by 18% year-on-year and by 3.3% since the previous quarter
The P/S is 21% lower than the 5-year quarterly average of 8.5 but 10% higher than the last 4 quarters average of 6.1
The company's revenue rose by 14% YoY

Efficiency

How efficient is Resmed business performance
The company's return on invested capital rose by 10% QoQ and by 2.2% YoY
Resmed's ROE has decreased by 8% YoY but it has increased by 3.3% from the previous quarter
The ROA has increased by 8% from the previous quarter but it has decreased by 3.4% YoY
The ROS has increased by 5% from the previous quarter

Dividends

What is RMD's dividend history
Dividend details
DPS
$1.92
Dividend yield
0.97%
Payout ratio
29.4%
Recent dividends

Financial health

How did Resmed financials performed over time
RMD's total liabilities is down by 21% year-on-year and by 10% since the previous quarter
Resmed's quick ratio has increased by 10% YoY and by 7% from the previous quarter
Resmed's debt is 75% lower than its equity
Resmed's debt to equity has decreased by 43% YoY and by 19% QoQ
Resmed's debt has decreased by 32% YoY and by 16% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.